US Patent Issued to UNIVERSITE DE LAUSANNE on Dec. 9 for "Methods and compositions for controlling cardiac fibrosis and remodeling" (Swiss Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,205, issued on Dec. 9, was assigned to UNIVERSITE DE LAUSANNE (Lausanne, Switzerland).

"Methods and compositions for controlling cardiac fibrosis and remodeling" was invented by Samir Ounzain (Lausanne, Switzerland) and Thierry Pedrazzini (Le Mont-sur-Lausanne, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods and compositions for controlling cardiac fibrosis and heart remodeling in a subject via modulating the expression of one or more lncRNA associated with cardiac-specific super-enhancers (SEs)."

The patent was filed on June 19, 2018, under Application No. 16/623,967.

*For further information, incl...